Adaptimmune Therapeutics plc - stock earnings
ADAP Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -48.3 million USD | 233009 USD |
| 2023Q3 | -45.6 million USD | 7.3 million USD |
| 2023Q2 | -21.4 million USD | 5.1 million USD |
| 2023Q1 | 1.0 million USD | 47.6 million USD |
| 2022Q4 | -29.3 million USD | 11.0 million USD |
| 2022Q3 | -41.4 million USD | 7.0 million USD |
| 2022Q2 | -44.5 million USD | 5.5 million USD |
| 2022Q1 | -50.3 million USD | 3.6 million USD |
| 2021Q4 | -38.9 million USD | 1.4 million USD |
| 2021Q3 | -42.4 million USD | 1.2 million USD |
| 2021Q2 | -39.1 million USD | 3.1 million USD |
| 2021Q1 | -37.8 million USD | 434000 USD |
| 2020Q4 | -36.6 million USD | 1.5 million USD |
| 2020Q3 | -35.4 million USD | 1.2 million USD |
| 2020Q2 | -29.9 million USD | 502000 USD |
| 2020Q1 | -28.2 million USD | 761000 USD |
| 2019Q4 | -29.4 million USD | 728000 USD |
| 2019Q3 | -39.3 million USD | 237000 USD |
| 2019Q2 | -41.1 million USD | 157000 USD |
| 2019Q1 | -27.4 million USD | ? USD |
| 2018Q4 | -36.2 million USD | 1.5 million USD |
| 2018Q3 | 5.2 million USD | 40.8 million USD |
| 2018Q2 | -43.8 million USD | 9.0 million USD |
| 2018Q1 | -21.1 million USD | 8.2 million USD |
| 2017Q4 | -27.3 million USD | 4.3 million USD |
| 2017Q3 | -878000 USD | 27.2 million USD |
| 2017Q2 | -20.2 million USD | 3.5 million USD |
| 2017Q1 | -21.8 million USD | 2.9 million USD |
| 2016Q4 | -15.4 million USD | 8.5 million USD |
| 2016Q3 | -18.5 million USD | 2.4 million USD |
| 2016Q2 | -22.1 million USD | 328000 USD |
| 2016Q1 | -15.6 million USD | 2.9 million USD |
| 2015Q4 | -39.5 million USD | 4.2 million USD |
| 2015Q3 | 4.9 million USD | 6.9 million USD |
| 2015Q2 | -22.1 million USD | 6.9 million USD |
| 2015Q1 | ? USD | 2.3 million USD |
| 2014Q4 | -1.6 million USD | 2.3 million USD |
| 2014Q3 | -3.3 million USD | 1.5 million USD |
| 2014Q2 | -11.6 million USD | 607000 USD |
ADAP Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -114.3 million USD | 60.5 million USD |
| 2022 | -165.5 million USD | 27.1 million USD |
| 2021 | -158.1 million USD | 6.1 million USD |
| 2020 | -130.1 million USD | 4.0 million USD |
| 2019 | -137.2 million USD | 1.1 million USD |
| 2018 | -95.5 million USD | 59.5 million USD |
| 2017 | -70.1 million USD | 37.8 million USD |
| 2016 | -71.6 million USD | 14.2 million USD |
| 2015 | -21.6 million USD | 10.7 million USD |
| 2014 | -21.6 million USD | 10.7 million USD |
| 2013 | -12.7 million USD | 604625 USD |
| 2012 | -8.5 million USD | ? USD |
ADAP
Price: $1.18
52 week price:
Earnings Per Share: -0.54 USD
P/E Ratio: -2.30
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 237100
Ebitda: 858000Market Capitalization: 318.4 million